Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Paratek Pharmaceuticals, Inc. (0001178711) Financials & SEC Data · SECfinAPI
Company
Paratek Pharmaceuticals, Inc. (0001178711)
Standardized SEC financial data for Paratek Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001178711 · Pharmaceutical Preparations.
Gross margin
85.6%
Operating margin
-28.8%
Net margin
-39.7%
Revenue growth (YoY)
241.6%
Return on equity
37.2%
ROIC
-70.7%
Free cash flow
-$66.2M
Debt / equity
-1.50×
Ratios for fiscal year 2022, standardized from SEC filings.